Officers, Board and Executive Committee

ARM Officers:

Robert Preti (ARM Officer: Chairman)
CEO & President | Read Bio
PCT, A Hitachi Group Company

Matt Patterson (ARM Officer: Vice Chairman)
President & CEO | Read Bio
Audentes Therapeutics

Martha Rook (ARM Officer: Secretary)
Head of Gene Editing and Novel Modalities
MilliporeSigma / EMD Millipore

Rahul Aras (ARM Officer: Treasurer) 
Co-Founder, President & CEO 
Juventas Therapeutics

ARM Board of Directors:

Zami Aberman
Chief Executive Officer
Pluristem Therapeutics

Martin Andrews
SVP, Rare Disease Head Unit
GlaxoSmith Kline (GSK)

Rahul Aras (ARM Officer: Treasurer) 
President and Chief Executive Officer | Read Bio
Juventas Therapeutics

Nessan Bermingham
CEO, President & Founder
Intellia Therapeutics

Eduardo Bravo

Managing Director & Chief Executive Officer | Read Bio
TiGenix

Olivier Danos
Senior Vice President, Gene Therapy
Biogen

Deborah Dean

Executive Vice President & Chief Compliance Officer

MiMedx

Douglas Doerfler
President and Chief Executive Officer | Read Bio
MaxCyte

Flagg Flanagan
Chief Executive Director | Read Bio
DiscGenics

Christian Homsy
CEO
Celyad

Andrea Hunt

Vice President, New Products TA Lead Gene Therapy, Neuroscience and Ophthalmology

Shire

Dena Ladd
Executive Director | Read Bio
Missouri Cures

Paul Laikind

President & CEO

ViaCyte

Edward Lanphier (Ex-Officio)
Founder and Chairman | Read Bio
Sangamo BioSciences

Michael May
Chief Executive Officer | Read Bio
Centre for Commercialization of Regenerative Medicine (CCRM)

Gregg Naeve
Head External R&D Innovation, ImmunoOncology & Rinat Labs
Pfizer

Tim Oldham

CEO & Executive Director

Cell Therapies Pty Ltd

Matt Patterson (ARM Officer: Vice Chairman)
President & CEO | Read Bio
Audentes Therapeutics

Robert Preti (ARM Officer: Chairman)
CEO & President | Read Bio
PCT, a Hitachi Group Company

Byung Geon ("BG") Rhee

President 

Green Cross Holdings

Isabelle Riviere
Director, Cell Therapy and Cell Engineering Facility
Memorial Sloan Kettering Cancer Center

Martha Rook (ARM Officer: Secretary)
Head of Gene Editing and Novel Modalities
MilliporeSigma / EMD Millipore

Jay Siegel
Chief Biotechnology Officer and Head, Scientific Strategy and Policy | Read Bio
Johnson & Johnson

Donna Skerrett
Chief Medical Officer | Read Bio
Mesoblast Limited

David Smith
Vice President, Global Business Development| Read Bio
Lonza

Keith Thompson
Chief Executive Officer | Read Bio
Cell
& Gene Therapy Catapult

Phil Vanek
General Manager, Cell Processing | Read Bio
GE Healthcare

Alexander Vos
Chief Executive Officer | Read Bio
PharmaCell

Jeff Walsh

Chief Financial and Strategy Officer
bluebird bio

Susan Washer
President & CEO
AGCT

Jason Wertheim

Assistant Professor of Surgery - Organ Transplantation, Department of Surgery, Institute for BioNanotechnology in Medicine, Feinberg School of Medicine and Chemistry of Life Processes Institute

Northwestern University

ARM Executive Committee:

Rahul Aras (ARM Officer: Treasurer) 
Co-Founder, President & CEO 
Juventas Therapeutics

Eduardo Bravo
Managing Director & Chief Executive Officer | Read Bio
TiGenix

Douglas Doerfler
President and Chief Executive Officer | Read Bio
MaxCyte

Karen Kozarsky
President
Vector BioPartners

Edward Lanphier (Ex-Officio)
Founder and Chairman | Read Bio
Sangamo BioSciences

Tom Novak
Vice President, Strategic Partnerships
Cellular Dynamics International

Matt Patterson (ARM Officer: Vice Chairman)
President & CEO | Read Bio
Audentes Therapeutics

Robert Preti (ARM Officer: Chairman)
CEO & President | Read Bio
PCT, a Hitachi Group Company

Martha Rook (ARM Officer: Secretary)

Head of Gene Editing and Novel Modalities

MilliporeSigma / EMD Millipore

Jay Siegel

Chief Biotechnology Officer and Head, Scientific Strategy and Policy

Johnson & Johnson

David Smith
Head, Cell Therapy Manufacturing | Read Bio
Lonza
Alexander Vos
Chief Executive Officer | Read Bio
PharmaCell